Terms: = Prostate cancer AND LDH
247 results:
1. Limited prognostic role of routine serum markers (AP, CEA, ldh and NSE) in oligorecurrent prostate cancer patients undergoing PSMA-radioguided surgery.
Mehring G; Steinbach C; Pose R; Knipper S; Koehler D; Werner S; Riethdorf S; von Amsberg G; Ambrosini F; Maurer T
World J Urol; 2024 Apr; 42(1):256. PubMed ID: 38656636
[TBL] [Abstract] [Full Text] [Related]
2. Calotropis procera extract inhibits prostate cancer through regulation of autophagy.
Singh P; Dhole B; Choudhury J; Tuli A; Pandey D; Velpandian T; Gupta S; Chaturvedi PK
J Cell Mol Med; 2024 Mar; 28(6):e18050. PubMed ID: 38400579
[TBL] [Abstract] [Full Text] [Related]
3. 1-Pyrroline-5-carboxylate inhibit T cell glycolysis in prostate cancer microenvironment by SHP1/PKM2/ldhB axis.
Chang L; Li G; Jiang S; Li J; Yang J; Shah K; Zhou L; Song H; Deng L; Luo Z; Guo Y; Yan Y
Cell Commun Signal; 2024 Feb; 22(1):101. PubMed ID: 38326896
[TBL] [Abstract] [Full Text] [Related]
4. Carvedilol induces pyroptosis through NLRP3-caspase1-ASC inflammasome by nuclear migration of NF-κB in prostate cancer models.
Zeng Y; Li MX; Wu SQ; Xu C
Mol Biol Rep; 2024 Jan; 51(1):201. PubMed ID: 38270665
[TBL] [Abstract] [Full Text] [Related]
5. Resistomycin Suppresses prostate cancer Cell Growth by Instigating Oxidative Stress, Mitochondrial Apoptosis, and Cell Cycle Arrest.
Aloufi AS; Habotta OA; Abdelfattah MS; Habib MN; Omran MM; Ali SA; Abdel Moneim AE; Korany SM; Alrajhi AM
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067602
[TBL] [Abstract] [Full Text] [Related]
6. Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy.
Handke A; Kesch C; Fendler WP; Telli T; Liu Y; Hakansson A; Davicioni E; Hughes J; Song H; Lueckerath K; Herrmann K; Hadaschik B; Seifert R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857524
[TBL] [Abstract] [Full Text] [Related]
7. A retrospective study: analysis of the relationship between lactate dehydrogenase and castration-resistant prostate cancer based on restricted cubic spline model.
Qiu R; Bu K; An H; Tao N
PeerJ; 2023; 11():e16158. PubMed ID: 37818332
[TBL] [Abstract] [Full Text] [Related]
8. TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive prostate cancer: A Real-World, Multicenter, Retrospective Analysis.
Pisano C; Turco F; Arnaudo E; Fea E; Vanella P; Ruatta F; Filippi R; Brusa F; Prati V; Vana F; Mennitto A; Cattrini C; Vignani F; Dionisio R; Icardi M; Guglielmini P; Buosi R; Stevani I; Vormola R; Numico G; Depetris I; Comandone A; Gennari A; Airoldi M; Rossi M; Vellani G; Ortega C; Tucci M; Maio MD; Buttigliero C
Clin Genitourin Cancer; 2024 Apr; 22(2):56-67.e16. PubMed ID: 37798164
[TBL] [Abstract] [Full Text] [Related]
9. Glycine Decarboxylase (GLDC) Plays a Crucial Role in Regulating Energy Metabolism, Invasion, Metastasis and Immune Escape for prostate cancer.
Chen MK; Xiao ZY; Huang ZP; Xue KY; Xia H; Zhou JW; Liao DY; Liang ZJ; Xie X; Wei QZ; Zhong L; Yang JK; Liu CD; Liu Y; Zhao SC
Int J Biol Sci; 2023; 19(15):4726-4743. PubMed ID: 37781511
[TBL] [Abstract] [Full Text] [Related]
10. The Apoptotic and Anti-Warburg Effects of Brassinin in PC-3 Cells via Reactive Oxygen Species Production and the Inhibition of the c-Myc, SIRT1, and β-Catenin Signaling Axis.
Kwon HH; Ahn CH; Lee HJ; Sim DY; Park JE; Park SY; Kim B; Shim BS; Kim SH
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762214
[TBL] [Abstract] [Full Text] [Related]
11. Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort study.
Yamada Y; Sakamoto S; Sato K; Saito S; Kanesaka M; Rii J; Kurokawa K; Tachiwaki D; Fukui Y; Shibata H; Goto Y; Sazuka T; Imamura Y; Nakatsu H; Ichikawa T
Prostate; 2023 Dec; 83(16):1610-1618. PubMed ID: 37690087
[TBL] [Abstract] [Full Text] [Related]
12. The diagnostic effectiveness of serum sialic acid predicts both qualitative and quantitative prostate cancer in patients with prostate-specific antigen between 4 and 20 ng/mL.
Sun J; Yan L
Front Endocrinol (Lausanne); 2023; 14():1188944. PubMed ID: 37645415
[TBL] [Abstract] [Full Text] [Related]
13. Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer.
Tian A; Wu T; Zhang Y; Chen J; Sha J; Xia W
Cell Oncol (Dordr); 2023 Dec; 46(6):1855-1870. PubMed ID: 37610690
[TBL] [Abstract] [Full Text] [Related]
14. Predictors of outcomes of docetaxel treatment in de novo metastatic hormone-sensitive prostate cancer: A single-center cohort study.
Omrčen T; Eterović D; Jozić T; Vrdoljak E
Neoplasma; 2023 Jun; 70(3):476-484. PubMed ID: 37498062
[TBL] [Abstract] [Full Text] [Related]
15. Treatment outcomes of radium-223 in patients with metastatic castration-resistant prostate cancer: An experience before National Health Insurance reimbursement in Taiwan.
Yu PH; Wei TT; Chang YH; Chung HJ; Huang EY; Lin TP; Huang WJ
J Chin Med Assoc; 2023 Aug; 86(8):756-761. PubMed ID: 37314313
[TBL] [Abstract] [Full Text] [Related]
16. Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant prostate cancer Patients Undergoing prostate-Specific Membrane Antigen-Directed Radioligand Therapy.
Hartrampf PE; Mihatsch PW; Seitz AK; Solnes LB; Rowe SP; Pomper MG; Kübler H; Bley TA; Buck AK; Werner RA
J Nucl Med; 2023 Aug; 64(8):1272-1278. PubMed ID: 37290794
[TBL] [Abstract] [Full Text] [Related]
17. Apoptotic and anti-Warburg effect of Morusin via ROS mediated inhibition of FOXM1/c-Myc signaling in prostate cancer cells.
Koo JI; Sim DY; Lee HJ; Ahn CH; Park J; Park SY; Lee D; Shim BS; Kim B; Kim SH
Phytother Res; 2023 Oct; 37(10):4473-4487. PubMed ID: 37288731
[TBL] [Abstract] [Full Text] [Related]
18. SUV
Hartrampf PE; Hüttmann T; Seitz AK; Kübler H; Serfling SE; Schlötelburg W; Michalski K; Rowe SP; Pomper MG; Buck AK; Eberlein U; Werner RA
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3465-3474. PubMed ID: 37272956
[TBL] [Abstract] [Full Text] [Related]
19. Proapoptotic effect of nonthermal pulsed ultrasound on prostate cancer cells in a nude mouse model.
Maeda K; Shigemura K; Hayashi F; Kan Y; Hiraoka A; Yamaguchi A; Ueda M; Yang YM; Maeshige N; Ooya T; Nakano Y; Fujisawa M
Prostate; 2023 Sep; 83(12):1217-1226. PubMed ID: 37221965
[TBL] [Abstract] [Full Text] [Related]
20. Flower-like core-shell nanostructures based on natural asphalt coated with Ni-ldh nanosheets as an electrochemical platform for prostate cancer biomarker sensing.
Farokhi S; Roushani M
Mikrochim Acta; 2023 May; 190(5):198. PubMed ID: 37126101
[TBL] [Abstract] [Full Text] [Related]
[Next]
